Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
Adobe
ADBE
KB Home
KBH
US Stock MarketDetailed Quotes
IOBT IO Biotech
- 0.942
- -0.038-3.87%
Close Dec 30 16:00 ET
- 0.940
- -0.002-0.22%
Post 20:01 ET
62.07MMarket Cap-0.73P/E (TTM)
1.060High0.931Low160.64KVolume0.980Open0.980Pre Close156.57KTurnover0.58%Turnover RatioLossP/E (Static)65.88MShares2.06052wk High0.86P/B26.17MFloat Cap0.66052wk Low--Dividend TTM27.78MShs Float17.880Historical High--Div YieldTTM13.20%Amplitude0.660Historical Low0.974Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
IO Biotech Stock Forum
IO Biotech Secures up to €57.5 Million in Debt Financing From the European Investment Bank
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...
loading...
No comment yet